Researchers at the University of Jyväskylä (Finland) have developed a new class of synthetic molecules that can capture sulfate, a widespread industrial and environmental contaminant, with ...

India’s CDSCO warns pharma companies against promoting prescription weight-loss drugs like Semaglutide and Liraglutide to the public, urging ethical marketing and holistic obesity care.

In cancer patients with brain metastases and type 2 diabetes, those using GLP-1 drugs had a 37% lower risk of death over 3 years. Significant mortality benefits were linked to semaglutide and ...

Biocon Biologics is among the leading global suppliers of biosimilar insulins and has been expanding its portfolio ...

A new study isolated DNA from the tumours of 500 cats across 13 different tumour types and mapped the sequence of 1,000 genes often found mutated in human cancers.

The use of romiplostim (Nplate) reduced treatment modifications due to chemotherapy-induced thrombocytopenia (CIT) in patients with gastrointestinal cancers, a phase III randomize ...

New $40 million raise brings Series A total to $100M, enabling advancement of VIM0423, a first-in-class oral therapeutic, into Phase 2 trials for isolated dystonia and for Parkinson’s diseaseFirst ...

Drugs originally designed to treat diabetes and obesity are reshaping medicine in unforeseen ways. Their impact on public health is really unprecedented in modern times, perhaps only upstaged by ...

Drugs based on semaglutide have become some of the most talked-about medicines in recent years. These drugs belong to a class ...

Researchers at the University of California San Diego have uncovered how a single protein triggers two opposite responses in blood vessels - one inflammatory and one protective. This protein, a ...

Thomas Smith Leerink Partners LLC, Research Division. Good morning, everyone. Thanks for joining us here at the Leerink Partners Global Healthcare Conference. My name is Tom Smith ...